Isolate Sequencing Services for Infection Prevention and Control

Outbreak Surveillance and Infection Prevention require accurate typing and characterization of bacterial isolates. Sequence your isolates with the pathogenomics- and AMR-experts at Ares Genetics and rely on the validated, AI powered ARESiss platform for accurate, comprehensive, and epidemiologically relevant data from microbial isolates.

Parcel icon

Bacterial Isolates or DNA

DNA icon

DNA Extraction

Test tube and machine

Sequencing

Data Analysis & Interpretation

monitor with mag glass icon

Comprehensive Reporting

Validated Accuracy

The ARESiss platform has been validated end-to-end using CLIA-grade processes to ensure accurate and reproducible isolate sequencing results.1

Express Turnaround

ARESiss Express sequencing and analysis in as little as 5 business days available upon request.

Globe icon

Your Benefits

Accurate surveillance

Reduce antibiotic use

Monitor trends and identify the emergence of new threats

Trace chains of transmission

Improve antimicrobial therapy through predictive AST

Spinning globe icon

We Offer

Express turnaround time of 5 days available upon request

Quality results based on validated ARESiss platform1

Access to reports via the AREScloud portal

Actionable intelligence on Pathogens and AMR

 

Sequencing
Sequencing icon

Whole genome sequencing
using short- or long-read technology
Data Analysis and Interpretation
Cloud with gear

Pathogen Characterization

ID & typing (cgMLST, MLST)
AMR marker profiling & annotation
Predictive AST
Virulence marker & plasmid profiling
 
Advanced Interpretation
Outbreak analysis (optional)
Custom analytics (optional)
Comprehensive Reporting
Monitor with mag glass icon

ARES
cloud
Web portal for reports and interpretation

Ares Genetics Expertise

An industry leading database and AI powered bioinformatics platform convert isolate genome data into epidemiologically actionable information.

Ares analytics enable accurate pathogen identification1,2 and AMR detection3 in line with FDA requirements for diagnostic antimicrobial susceptibility test (AST) systems.4

Predictive AST is the prediction of antimicrobial susceptibility profiles from genomic data. Resistance markers tell only one side of the story. Whether a pathogen is susceptible to antibiotic therapy can depend on a combination of different genes and genomic mutations. Unlike other solutions that purely rely on AMR gene detection, Ares Genetics aims to set the standard for AI-powered predictive antibiotic susceptibility testing (predictive AST).2,3,5,6,7 Predictive models for a wide range of pathogen-drug combinations are trained using an industry-leading collection of continuously curated clinical pathogen genomes and associated antibiotic susceptibility profiles.

AI Gear icon

ARESai

ARESai uses machine learning efforts aimed to set the industry standard for AI-powered infectious disease testing in accordance with FDA guidelines.8,9

Database icon

ARESdb

ARESdb is a comprehensive collection of resistance-associated genes and genetic markers for AMR. ARESdb also stores training data and AI predictive models.

Clipboard icon

AREScloud

AREScloud is a web-based, user-friendly portal to Isolate Reports and an interface enabling decentralized NGS- based Isolate Analysis for reference labs and medical centers.


  1. Lepuschitz, S. et al. Front Microbiol 11, 1883 (2020). doi: 10.3389/fmicb.2020.01883
  2. Beisken, S. et al. (2021). https://www.opgen.com/multicenter/
  3. Ferreira, I. et al. J Clin Microbiol 58, (2020). doi: 10.1128/jcm.00273-20
  4. Reller, L. B. et al. Clin Infect Dis 49, 1749–1755 (2009). doi: 10.1086/647952
  5. Volz, C. et al. Front Microbiol 10, 1671 (2019). doi: 10.3389/fmicb.2019.01671
  6. Galata, V. et al. Genom Proteom Bioinform 17, 169–182 (2019). doi: 10.1016/j.gpb.2018.11.002
  7. Mahfouz, N. et al. J Antimicrob Chemoth 75, dkaa257- (2020). doi: 10.1093/jac/dkaa257
  8. U.S. Food & Drug Administration. Accessed April 16, 2022. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device (2021)
  9. Lüftinger, L. et al. Front Cell Infect Mi 11, 610348 (2021). doi: 10.3389/fcimb.2021.610348

 

For Research Use Only. Not for use in diagnostic procedures.